Shimazui Toru, Kojima Takahiro, Onozawa Mizuki, Suzuki Masahiko, Asano Taeko, Akaza Hideyuki
Department of Urology, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki 305-8575, Japan.
Oncol Rep. 2006 May;15(5):1181-4.
Renal cell carcinomas (RCCs) primarily express cadherin-6 and N-cadherin rather than E-cadherin, and the aberrant expression of cadherin-6 correlates with a poor prognosis in patients with E-cadherin-absent RCC. However, the role of N-cadherin in RCC has not yet been elucidated. In this study, we analyze the expression pattern of N-cadherin in surgical RCC specimens and discuss the function of N-cadherin in RCC together with a re-evaluation of our previous study. Forty-six surgically resected RCC specimens were used in this study. The expression and localization of E-cadherin and N-cadherin in surgical specimens were demonstrated by immunohistochemistry. Correlations between the expression pattern of each cadherin, pathological parameters and patient survival were analyzed. RCC specimens expressed N-cadherin as a normal pattern despite the elevation of tumor grade, and patients with N-cadherin-normal RCC had a poorer prognosis than those with N-cadherin-abnormal RCC. Since our previous study showed that N-cadherin only functioned in cell attachment when E-cadherin and cadherin-6 were impaired, N-cadherin plays a different role from E-cadherin or cadherin-6 in RCC and may be associated with the aggressiveness and malignant potential of RCC.
肾细胞癌(RCCs)主要表达钙黏蛋白-6和N-钙黏蛋白,而非E-钙黏蛋白,并且在缺乏E-钙黏蛋白的肾细胞癌患者中,钙黏蛋白-6的异常表达与预后不良相关。然而,N-钙黏蛋白在肾细胞癌中的作用尚未阐明。在本研究中,我们分析了N-钙黏蛋白在手术切除的肾细胞癌标本中的表达模式,并结合对我们先前研究的重新评估,探讨了N-钙黏蛋白在肾细胞癌中的功能。本研究使用了46例手术切除的肾细胞癌标本。通过免疫组织化学检测手术标本中E-钙黏蛋白和N-钙黏蛋白的表达及定位。分析了每种钙黏蛋白的表达模式、病理参数与患者生存率之间的相关性。尽管肿瘤分级升高,但肾细胞癌标本仍以正常模式表达N-钙黏蛋白,N-钙黏蛋白表达正常的肾细胞癌患者的预后比N-钙黏蛋白表达异常的患者更差。由于我们先前的研究表明,当E-钙黏蛋白和钙黏蛋白-6受损时,N-钙黏蛋白仅在细胞黏附中起作用,因此N-钙黏蛋白在肾细胞癌中发挥的作用与E-钙黏蛋白或钙黏蛋白-6不同,可能与肾细胞癌的侵袭性和恶性潜能有关。